This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D) to avoid acute complications at diagnosis and to allow earlier interventions to prevent and/or delay clinical manifestations and long term complications of the disease.
Deadlines:
Letter of Intent Due Date(s): January 17, 2022 and September 07, 2022
Application Due Date(s): February 17, 2022 and October 7, 2022
RFA-DK-21-021 Expiration Date October 08, 2022
Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
Budgets up to $300,000 total costs per project for Phase I and up to $2,000,000 total costs per project for Phase II may be requested.
